Boris Reva
Papers
1
Total Citations
15
H-Index
1
About
Boris Reva is a leading cancer researcher whose work bridges computational biology and clinical oncology, with a focus on prostate cancer (PCa) and tumor immunology. His key research areas include the tumor microenvironment, inflammation-driven cancer progression, and the molecular determinants of aggressive disease. Reva’s most cited study, “Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer” (2022, 15 citations), is a landmark investigation that for the first time systematically evaluated how pelvic inflammation influences PCa biology and clinical outcomes after radical prostatectomy. This work has opened new avenues for understanding the role of chronic inflammation in driving aggressive tumor phenotypes, offering potential biomarkers for risk stratification. Beyond this, Reva has contributed to large-scale genomic analyses and the development of computational tools for cancer data integration. His research is notable for its translational impact, directly informing clinical decision-making and therapeutic targeting. With a growing citation record and a reputation for innovative, interdisciplinary approaches, Boris Reva is shaping how we understand the interplay between inflammation and cancer aggressiveness, making his work essential reading for students and researchers in oncology and immunology.
Research Focus
Key Achievements
Top Papers
- 1